Chabriat H; Bassetti CL; Marx U; Audoli-Inthavong ML; Sors A; Lambert E; Wattez M; Hermann DM; ALTHAUS K; AMARO S; BAE HJ; BAK Z; BARBARINI L; BASSI P; BAZAN R; BERECZKI D; BERKOWICZ T; BERROUSCHOT J; BLACQUIERE D; BROLA W; BUTCHER K; CARDONA P; CHA JK; CLOUD G; COHEN D; CORDONNIER C; CSANYI A; CZLONKOWSKA A; DAVIS S; DAWSON J; DE KLIPPEL N; DENIER C; DESFONTAINES P; DIENER HC; DIOSZEGHY P; DIPPEL DW; DORADO L; FOLYOVICH A; FREITAS GR; FRIEDRICH MA; FRYZE W; GAGLIARDI RJ; GOTTSCHAL M; GRIMLEY R; GROND M; GRÖSCHEL K; HOSSEINI H; HWANG Y; KALLMUENZER B; KHAN U; KIM JS; KLEINIG T; KOVES A; LAGO MARTIN A; LASEK-BAL A; LEMBO G; LEMMENS R; LINDERT R; PORCELLO MARRONE LC; MARTINEZ ZABALETA M; MAS JL; MASJUAN VALLEJO J; MAZIGHI M; MINELLI C; MISTRI A; MOLINA C; MONICHE ALVAREZ F; CABRAL MORO CH; MULLENERS W; NABAVI D; NEAU JP; O'BRIEN B; OVARY C; PANCZEL G; PARK MS; PHAN T; RAGAB S; REJDAK K; ROFFE C; ROQUER GONZALEZ J; ROVER L; SAMPAIO SILVA G; SCHELLINGER P; SEGURA MARTIN T; SHAW L; SIBON I; SKODA O; SMADJA D; SOBOLEWSKI P; SODA H; SPRIGG N; SWIAT M; SZAPARY L; SZEGEDI N; TONI D; VALIKOVICS A; VANHOOREN G; VECSEI L; WEIN T; WONG A, 2020, 'Safety and efficacy of GABAA α5 antagonist S44819 in patients with ischaemic stroke: a multicentre, double-blind, randomised, placebo-controlled trial',
The Lancet Neurology, vol. 19, pp. 226 - 233,
http://dx.doi.org/10.1016/S1474-4422(20)30004-1